カテゴリー： QYResearch, 世界

世界の免疫性血小板減少性紫斑病治療薬市場 2019年

【英語タイトル】Global Immune Thrombocytopenic Purpura Therapeutics Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X09560）・商品コード：DATA909X09560
・発行会社（調査会社）：QYResearch
・発行日：2019年11月20日（※2024年版があります。お問い合わせください）
・ページ数：110
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、免疫性血小板減少性紫斑病治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、エルトロンボパグオラミン、フォスタマチニブ二ナトリウム、GL-2045、アバトロンボパグ、BI-655064、その他に、用途別には、病院、診療所、その他にセグメント区分し、免疫性血小板減少性紫斑病治療薬の世界市場を分析しました。


・エグゼクティブ・サマリー
・免疫性血小板減少性紫斑病治療薬の世界市場概要
・免疫性血小板減少性紫斑病治療薬の製造コスト構成分析
・免疫性血小板減少性紫斑病治療薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・免疫性血小板減少性紫斑病治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・免疫性血小板減少性紫斑病治療薬のセグメント分析（種類別）
（エルトロンボパグオラミン、フォスタマチニブ二ナトリウム、GL-2045、アバトロンボパグ、BI-655064、その他）
・免疫性血小板減少性紫斑病治療薬のセグメント分析（用途別）
（病院、診療所、その他）
・免疫性血小板減少性紫斑病治療薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Amgen Inc.、Baxalta Incorporated、Boehringer Ingelheim GmbH、Bristol-Myers Squibb Company、Eisai、Hansa Medical AB、Immunomedics, Inc.、Intas Pharmaceuticals Ltd.、Jiangsu Hengrui Medicine Co., Ltd.、Merck & Co., Inc.、Momenta Pharmaceuticals, Inc.、Novartis AG、Pfizer Inc.、）
・免疫性血小板減少性紫斑病治療薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Immune Thrombocytopenic Purpura Therapeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Immune Thrombocytopenic Purpura Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Immune Thrombocytopenic Purpura Therapeutics market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Immune Thrombocytopenic Purpura Therapeutics in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Immune Thrombocytopenic Purpura Therapeutics manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Amgen Inc.
Baxalta Incorporated
Boehringer Ingelheim GmbH
Bristol-Myers Squibb Company
Eisai
Hansa Medical AB
Immunomedics, Inc.
Intas Pharmaceuticals Ltd.
Jiangsu Hengrui Medicine Co., Ltd.
Merck & Co., Inc.
Momenta Pharmaceuticals, Inc.
Novartis AG
Pfizer Inc.

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Eltrombopag Olamine
Fostamatinib Disodium
GL-2045
Avatrombopag
BI-655064
Others

Segment by Application
Hospital
Clinic
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Immune Thrombocytopenic Purpura Therapeutics
1.1 Definition of Immune Thrombocytopenic Purpura Therapeutics
1.2 Immune Thrombocytopenic Purpura Therapeutics Segment by Type
1.2.1 Global Immune Thrombocytopenic Purpura Therapeutics Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Eltrombopag Olamine
1.2.3 Fostamatinib Disodium
1.2.4 GL-2045
1.2.5 Avatrombopag
1.2.6 BI-655064
1.2.7 Others
1.3 Immune Thrombocytopenic Purpura Therapeutics Segment by Applications
1.3.1 Global Immune Thrombocytopenic Purpura Therapeutics Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Immune Thrombocytopenic Purpura Therapeutics Overall Market
1.4.1 Global Immune Thrombocytopenic Purpura Therapeutics Revenue (2014-2025)
1.4.2 Global Immune Thrombocytopenic Purpura Therapeutics Production (2014-2025)
1.4.3 North America Immune Thrombocytopenic Purpura Therapeutics Status and Prospect (2014-2025)
1.4.4 Europe Immune Thrombocytopenic Purpura Therapeutics Status and Prospect (2014-2025)
1.4.5 China Immune Thrombocytopenic Purpura Therapeutics Status and Prospect (2014-2025)
1.4.6 Japan Immune Thrombocytopenic Purpura Therapeutics Status and Prospect (2014-2025)
1.4.7 Southeast Asia Immune Thrombocytopenic Purpura Therapeutics Status and Prospect (2014-2025)
1.4.8 India Immune Thrombocytopenic Purpura Therapeutics Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Immune Thrombocytopenic Purpura Therapeutics
2.3 Manufacturing Process Analysis of Immune Thrombocytopenic Purpura Therapeutics
2.4 Industry Chain Structure of Immune Thrombocytopenic Purpura Therapeutics

3 Development and Manufacturing Plants Analysis of Immune Thrombocytopenic Purpura Therapeutics
3.1 Capacity and Commercial Production Date
3.2 Global Immune Thrombocytopenic Purpura Therapeutics Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Immune Thrombocytopenic Purpura Therapeutics
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Immune Thrombocytopenic Purpura Therapeutics Production and Capacity Analysis
4.2 Immune Thrombocytopenic Purpura Therapeutics Revenue Analysis
4.3 Immune Thrombocytopenic Purpura Therapeutics Price Analysis
4.4 Market Concentration Degree

5 Immune Thrombocytopenic Purpura Therapeutics Regional Market Analysis
5.1 Immune Thrombocytopenic Purpura Therapeutics Production by Regions
5.1.1 Global Immune Thrombocytopenic Purpura Therapeutics Production by Regions
5.1.2 Global Immune Thrombocytopenic Purpura Therapeutics Revenue by Regions
5.2 Immune Thrombocytopenic Purpura Therapeutics Consumption by Regions
5.3 North America Immune Thrombocytopenic Purpura Therapeutics Market Analysis
5.3.1 North America Immune Thrombocytopenic Purpura Therapeutics Production
5.3.2 North America Immune Thrombocytopenic Purpura Therapeutics Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Immune Thrombocytopenic Purpura Therapeutics Import and Export
5.4 Europe Immune Thrombocytopenic Purpura Therapeutics Market Analysis
5.4.1 Europe Immune Thrombocytopenic Purpura Therapeutics Production
5.4.2 Europe Immune Thrombocytopenic Purpura Therapeutics Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Immune Thrombocytopenic Purpura Therapeutics Import and Export
5.5 China Immune Thrombocytopenic Purpura Therapeutics Market Analysis
5.5.1 China Immune Thrombocytopenic Purpura Therapeutics Production
5.5.2 China Immune Thrombocytopenic Purpura Therapeutics Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Immune Thrombocytopenic Purpura Therapeutics Import and Export
5.6 Japan Immune Thrombocytopenic Purpura Therapeutics Market Analysis
5.6.1 Japan Immune Thrombocytopenic Purpura Therapeutics Production
5.6.2 Japan Immune Thrombocytopenic Purpura Therapeutics Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Immune Thrombocytopenic Purpura Therapeutics Import and Export
5.7 Southeast Asia Immune Thrombocytopenic Purpura Therapeutics Market Analysis
5.7.1 Southeast Asia Immune Thrombocytopenic Purpura Therapeutics Production
5.7.2 Southeast Asia Immune Thrombocytopenic Purpura Therapeutics Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Immune Thrombocytopenic Purpura Therapeutics Import and Export
5.8 India Immune Thrombocytopenic Purpura Therapeutics Market Analysis
5.8.1 India Immune Thrombocytopenic Purpura Therapeutics Production
5.8.2 India Immune Thrombocytopenic Purpura Therapeutics Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Immune Thrombocytopenic Purpura Therapeutics Import and Export

6 Immune Thrombocytopenic Purpura Therapeutics Segment Market Analysis (by Type)
6.1 Global Immune Thrombocytopenic Purpura Therapeutics Production by Type
6.2 Global Immune Thrombocytopenic Purpura Therapeutics Revenue by Type
6.3 Immune Thrombocytopenic Purpura Therapeutics Price by Type

7 Immune Thrombocytopenic Purpura Therapeutics Segment Market Analysis (by Application)
7.1 Global Immune Thrombocytopenic Purpura Therapeutics Consumption by Application
7.2 Global Immune Thrombocytopenic Purpura Therapeutics Consumption Market Share by Application (2014-2019)

8 Immune Thrombocytopenic Purpura Therapeutics Major Manufacturers Analysis
8.1 Amgen Inc.
8.1.1 Amgen Inc. Immune Thrombocytopenic Purpura Therapeutics Production Sites and Area Served
8.1.2 Amgen Inc. Product Introduction, Application and Specification
8.1.3 Amgen Inc. Immune Thrombocytopenic Purpura Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Baxalta Incorporated
8.2.1 Baxalta Incorporated Immune Thrombocytopenic Purpura Therapeutics Production Sites and Area Served
8.2.2 Baxalta Incorporated Product Introduction, Application and Specification
8.2.3 Baxalta Incorporated Immune Thrombocytopenic Purpura Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Boehringer Ingelheim GmbH
8.3.1 Boehringer Ingelheim GmbH Immune Thrombocytopenic Purpura Therapeutics Production Sites and Area Served
8.3.2 Boehringer Ingelheim GmbH Product Introduction, Application and Specification
8.3.3 Boehringer Ingelheim GmbH Immune Thrombocytopenic Purpura Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Bristol-Myers Squibb Company
8.4.1 Bristol-Myers Squibb Company Immune Thrombocytopenic Purpura Therapeutics Production Sites and Area Served
8.4.2 Bristol-Myers Squibb Company Product Introduction, Application and Specification
8.4.3 Bristol-Myers Squibb Company Immune Thrombocytopenic Purpura Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Eisai
8.5.1 Eisai Immune Thrombocytopenic Purpura Therapeutics Production Sites and Area Served
8.5.2 Eisai Product Introduction, Application and Specification
8.5.3 Eisai Immune Thrombocytopenic Purpura Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Hansa Medical AB
8.6.1 Hansa Medical AB Immune Thrombocytopenic Purpura Therapeutics Production Sites and Area Served
8.6.2 Hansa Medical AB Product Introduction, Application and Specification
8.6.3 Hansa Medical AB Immune Thrombocytopenic Purpura Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Immunomedics, Inc.
8.7.1 Immunomedics, Inc. Immune Thrombocytopenic Purpura Therapeutics Production Sites and Area Served
8.7.2 Immunomedics, Inc. Product Introduction, Application and Specification
8.7.3 Immunomedics, Inc. Immune Thrombocytopenic Purpura Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Intas Pharmaceuticals Ltd.
8.8.1 Intas Pharmaceuticals Ltd. Immune Thrombocytopenic Purpura Therapeutics Production Sites and Area Served
8.8.2 Intas Pharmaceuticals Ltd. Product Introduction, Application and Specification
8.8.3 Intas Pharmaceuticals Ltd. Immune Thrombocytopenic Purpura Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Jiangsu Hengrui Medicine Co., Ltd.
8.9.1 Jiangsu Hengrui Medicine Co., Ltd. Immune Thrombocytopenic Purpura Therapeutics Production Sites and Area Served
8.9.2 Jiangsu Hengrui Medicine Co., Ltd. Product Introduction, Application and Specification
8.9.3 Jiangsu Hengrui Medicine Co., Ltd. Immune Thrombocytopenic Purpura Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Merck & Co., Inc.
8.10.1 Merck & Co., Inc. Immune Thrombocytopenic Purpura Therapeutics Production Sites and Area Served
8.10.2 Merck & Co., Inc. Product Introduction, Application and Specification
8.10.3 Merck & Co., Inc. Immune Thrombocytopenic Purpura Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Momenta Pharmaceuticals, Inc.
8.12 Novartis AG
8.13 Pfizer Inc.

9 Development Trend of Analysis of Immune Thrombocytopenic Purpura Therapeutics Market
9.1 Global Immune Thrombocytopenic Purpura Therapeutics Market Trend Analysis
9.1.1 Global Immune Thrombocytopenic Purpura Therapeutics Market Size (Volume and Value) Forecast 2019-2025
9.2 Immune Thrombocytopenic Purpura Therapeutics Regional Market Trend
9.2.1 North America Immune Thrombocytopenic Purpura Therapeutics Forecast 2019-2025
9.2.2 Europe Immune Thrombocytopenic Purpura Therapeutics Forecast 2019-2025
9.2.3 China Immune Thrombocytopenic Purpura Therapeutics Forecast 2019-2025
9.2.4 Japan Immune Thrombocytopenic Purpura Therapeutics Forecast 2019-2025
9.2.5 Southeast Asia Immune Thrombocytopenic Purpura Therapeutics Forecast 2019-2025
9.2.6 India Immune Thrombocytopenic Purpura Therapeutics Forecast 2019-2025
9.3 Immune Thrombocytopenic Purpura Therapeutics Market Trend (Product Type)
9.4 Immune Thrombocytopenic Purpura Therapeutics Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Immune Thrombocytopenic Purpura Therapeutics Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Immune Thrombocytopenic Purpura Therapeutics
Table Global Immune Thrombocytopenic Purpura Therapeutics Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Immune Thrombocytopenic Purpura Therapeutics Production Market Share by Types in 2018
Figure Eltrombopag Olamine Product Picture
Figure Fostamatinib Disodium Product Picture
Figure GL-2045 Product Picture
Figure Avatrombopag Product Picture
Figure BI-655064 Product Picture
Figure Others Product Picture
Table Global Immune Thrombocytopenic Purpura Therapeutics Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Immune Thrombocytopenic Purpura Therapeutics Consumption Market Share by Applications in 2018
Figure Hospital
Figure Clinic
Figure Others
Figure Global Immune Thrombocytopenic Purpura Therapeutics Revenue (Million USD) (2014-2025)
Figure Global Immune Thrombocytopenic Purpura Therapeutics Production (K Pcs) (2014-2025)
Figure North America Immune Thrombocytopenic Purpura Therapeutics Market Size (Million USD) (2014-2025)
Figure Europe Immune Thrombocytopenic Purpura Therapeutics Market Size (Million USD) (2014-2025)
Figure China Immune Thrombocytopenic Purpura Therapeutics Market Size (Million USD) (2014-2025)
Figure Japan Immune Thrombocytopenic Purpura Therapeutics Market Size (Million USD) (2014-2025)
Figure Southeast Asia Immune Thrombocytopenic Purpura Therapeutics Market Size (Million USD) (2014-2025)
Figure India Immune Thrombocytopenic Purpura Therapeutics Market Size (Million USD) (2014-2025)
Table Immune Thrombocytopenic Purpura Therapeutics Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Immune Thrombocytopenic Purpura Therapeutics in 2018
Figure Manufacturing Process Analysis of Immune Thrombocytopenic Purpura Therapeutics
Figure Industry Chain Structure of Immune Thrombocytopenic Purpura Therapeutics
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Immune Thrombocytopenic Purpura Therapeutics Manufacturing Plants Distribution
Table Immune Thrombocytopenic Purpura Therapeutics Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Immune Thrombocytopenic Purpura Therapeutics Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Immune Thrombocytopenic Purpura Therapeutics Production (K Pcs) of Major Manufacturers (2014-2019)
Table Immune Thrombocytopenic Purpura Therapeutics Production Market Share of Major Manufacturers (2014-2019)
Figure Immune Thrombocytopenic Purpura Therapeutics Production Share by Manufacturers in 2018
Table Immune Thrombocytopenic Purpura Therapeutics Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Immune Thrombocytopenic Purpura Therapeutics Revenue Market Share of Major Manufacturers (2014-2019)
Figure Immune Thrombocytopenic Purpura Therapeutics Revenue Share by Manufacturers in 2018
Table Immune Thrombocytopenic Purpura Therapeutics Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Immune Thrombocytopenic Purpura Therapeutics Production by Regions 2014-2019 (K Pcs)
Table Global Immune Thrombocytopenic Purpura Therapeutics Production Market Share by Regions 2014-2019
Figure Global Immune Thrombocytopenic Purpura Therapeutics Production Market Share by Regions in 2018
Table Global Immune Thrombocytopenic Purpura Therapeutics Revenue by Regions 2014-2019 (Million USD)
Table Global Immune Thrombocytopenic Purpura Therapeutics Revenue Market Share by Regions 2014-2019
Figure Global Immune Thrombocytopenic Purpura Therapeutics Revenue Market Share by Regions in 2018
Table Global Immune Thrombocytopenic Purpura Therapeutics Consumption by Regions 2014-2019 (K Pcs)
Table Global Immune Thrombocytopenic Purpura Therapeutics Consumption Market Share by Regions 2014-2019
Figure North America Immune Thrombocytopenic Purpura Therapeutics Production Growth Rate 2014-2019 (K Pcs)
Figure North America Immune Thrombocytopenic Purpura Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table North America Immune Thrombocytopenic Purpura Therapeutics Production, Consumption Import and Export (K Pcs)
Figure Europe Immune Thrombocytopenic Purpura Therapeutics Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Immune Thrombocytopenic Purpura Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Immune Thrombocytopenic Purpura Therapeutics Production, Consumption Import and Export (K Pcs)
Figure China Immune Thrombocytopenic Purpura Therapeutics Production Growth Rate 2014-2019 (K Pcs)
Figure China Immune Thrombocytopenic Purpura Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table China Immune Thrombocytopenic Purpura Therapeutics Production, Consumption Import and Export (K Pcs)
Figure Japan Immune Thrombocytopenic Purpura Therapeutics Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Immune Thrombocytopenic Purpura Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Immune Thrombocytopenic Purpura Therapeutics Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Immune Thrombocytopenic Purpura Therapeutics Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Immune Thrombocytopenic Purpura Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Immune Thrombocytopenic Purpura Therapeutics Production, Consumption Import and Export (K Pcs)
Figure India Immune Thrombocytopenic Purpura Therapeutics Production Growth Rate 2014-2019 (K Pcs)
Figure India Immune Thrombocytopenic Purpura Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table India Immune Thrombocytopenic Purpura Therapeutics Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Immune Thrombocytopenic Purpura Therapeutics Market Share by Application (2014-2019)
Figure Global Value (Consumption) Immune Thrombocytopenic Purpura Therapeutics Market Share by Application (2014-2019)
Table Amgen Inc. Immune Thrombocytopenic Purpura Therapeutics Production Sites and Area Served
Table Amgen Inc. Immune Thrombocytopenic Purpura Therapeutics Product Introduction, Application and Specification
Table Amgen Inc. Immune Thrombocytopenic Purpura Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Amgen Inc. Immune Thrombocytopenic Purpura Therapeutics Production Growth Rate (2014-2019)
Table Amgen Inc. Immune Thrombocytopenic Purpura Therapeutics Production Market Share (2014-2019)
Figure Amgen Inc. Immune Thrombocytopenic Purpura Therapeutics Revenue Market Share (2014-2019)
Table Amgen Inc. Immune Thrombocytopenic Purpura Therapeutics Main Business and Markets Served
Table Baxalta Incorporated Immune Thrombocytopenic Purpura Therapeutics Production Sites and Area Served
Table Baxalta Incorporated Immune Thrombocytopenic Purpura Therapeutics Product Introduction, Application and Specification
Table Baxalta Incorporated Immune Thrombocytopenic Purpura Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Baxalta Incorporated Immune Thrombocytopenic Purpura Therapeutics Production Growth Rate (2014-2019)
Table Baxalta Incorporated Immune Thrombocytopenic Purpura Therapeutics Production Market Share (2014-2019)
Figure Baxalta Incorporated Immune Thrombocytopenic Purpura Therapeutics Revenue Market Share (2014-2019)
Table Baxalta Incorporated Immune Thrombocytopenic Purpura Therapeutics Main Business and Markets Served
Table Boehringer Ingelheim GmbH Immune Thrombocytopenic Purpura Therapeutics Production Sites and Area Served
Table Boehringer Ingelheim GmbH Immune Thrombocytopenic Purpura Therapeutics Product Introduction, Application and Specification
Table Boehringer Ingelheim GmbH Immune Thrombocytopenic Purpura Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Boehringer Ingelheim GmbH Immune Thrombocytopenic Purpura Therapeutics Production Growth Rate (2014-2019)
Table Boehringer Ingelheim GmbH Immune Thrombocytopenic Purpura Therapeutics Production Market Share (2014-2019)
Figure Boehringer Ingelheim GmbH Immune Thrombocytopenic Purpura Therapeutics Revenue Market Share (2014-2019)
Table Boehringer Ingelheim GmbH Immune Thrombocytopenic Purpura Therapeutics Main Business and Markets Served
Table Bristol-Myers Squibb Company Immune Thrombocytopenic Purpura Therapeutics Production Sites and Area Served
Table Bristol-Myers Squibb Company Immune Thrombocytopenic Purpura Therapeutics Product Introduction, Application and Specification
Table Bristol-Myers Squibb Company Immune Thrombocytopenic Purpura Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Bristol-Myers Squibb Company Immune Thrombocytopenic Purpura Therapeutics Production Growth Rate (2014-2019)
Table Bristol-Myers Squibb Company Immune Thrombocytopenic Purpura Therapeutics Production Market Share (2014-2019)
Figure Bristol-Myers Squibb Company Immune Thrombocytopenic Purpura Therapeutics Revenue Market Share (2014-2019)
Table Bristol-Myers Squibb Company Immune Thrombocytopenic Purpura Therapeutics Main Business and Markets Served
Table Eisai Immune Thrombocytopenic Purpura Therapeutics Production Sites and Area Served
Table Eisai Immune Thrombocytopenic Purpura Therapeutics Product Introduction, Application and Specification
Table Eisai Immune Thrombocytopenic Purpura Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Eisai Immune Thrombocytopenic Purpura Therapeutics Production Growth Rate (2014-2019)
Table Eisai Immune Thrombocytopenic Purpura Therapeutics Production Market Share (2014-2019)
Figure Eisai Immune Thrombocytopenic Purpura Therapeutics Revenue Market Share (2014-2019)
Table Eisai Immune Thrombocytopenic Purpura Therapeutics Main Business and Markets Served
Table Hansa Medical AB Immune Thrombocytopenic Purpura Therapeutics Production Sites and Area Served
Table Hansa Medical AB Immune Thrombocytopenic Purpura Therapeutics Product Introduction, Application and Specification
Table Hansa Medical AB Immune Thrombocytopenic Purpura Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Hansa Medical AB Immune Thrombocytopenic Purpura Therapeutics Production Growth Rate (2014-2019)
Table Hansa Medical AB Immune Thrombocytopenic Purpura Therapeutics Production Market Share (2014-2019)
Figure Hansa Medical AB Immune Thrombocytopenic Purpura Therapeutics Revenue Market Share (2014-2019)
Table Hansa Medical AB Immune Thrombocytopenic Purpura Therapeutics Main Business and Markets Served
Table Immunomedics, Inc. Immune Thrombocytopenic Purpura Therapeutics Production Sites and Area Served
Table Immunomedics, Inc. Immune Thrombocytopenic Purpura Therapeutics Product Introduction, Application and Specification
Table Immunomedics, Inc. Immune Thrombocytopenic Purpura Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Immunomedics, Inc. Immune Thrombocytopenic Purpura Therapeutics Production Growth Rate (2014-2019)
Table Immunomedics, Inc. Immune Thrombocytopenic Purpura Therapeutics Production Market Share (2014-2019)
Figure Immunomedics, Inc. Immune Thrombocytopenic Purpura Therapeutics Revenue Market Share (2014-2019)
Table Immunomedics, Inc. Immune Thrombocytopenic Purpura Therapeutics Main Business and Markets Served
Table Intas Pharmaceuticals Ltd. Immune Thrombocytopenic Purpura Therapeutics Production Sites and Area Served
Table Intas Pharmaceuticals Ltd. Immune Thrombocytopenic Purpura Therapeutics Product Introduction, Application and Specification
Table Intas Pharmaceuticals Ltd. Immune Thrombocytopenic Purpura Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Intas Pharmaceuticals Ltd. Immune Thrombocytopenic Purpura Therapeutics Production Growth Rate (2014-2019)
Table Intas Pharmaceuticals Ltd. Immune Thrombocytopenic Purpura Therapeutics Production Market Share (2014-2019)
Figure Intas Pharmaceuticals Ltd. Immune Thrombocytopenic Purpura Therapeutics Revenue Market Share (2014-2019)
Table Intas Pharmaceuticals Ltd. Immune Thrombocytopenic Purpura Therapeutics Main Business and Markets Served
Table Jiangsu Hengrui Medicine Co., Ltd. Immune Thrombocytopenic Purpura Therapeutics Production Sites and Area Served
Table Jiangsu Hengrui Medicine Co., Ltd. Immune Thrombocytopenic Purpura Therapeutics Product Introduction, Application and Specification
Table Jiangsu Hengrui Medicine Co., Ltd. Immune Thrombocytopenic Purpura Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Jiangsu Hengrui Medicine Co., Ltd. Immune Thrombocytopenic Purpura Therapeutics Production Growth Rate (2014-2019)
Table Jiangsu Hengrui Medicine Co., Ltd. Immune Thrombocytopenic Purpura Therapeutics Production Market Share (2014-2019)
Figure Jiangsu Hengrui Medicine Co., Ltd. Immune Thrombocytopenic Purpura Therapeutics Revenue Market Share (2014-2019)
Table Jiangsu Hengrui Medicine Co., Ltd. Immune Thrombocytopenic Purpura Therapeutics Main Business and Markets Served
Table Merck & Co., Inc. Immune Thrombocytopenic Purpura Therapeutics Production Sites and Area Served
Table Merck & Co., Inc. Immune Thrombocytopenic Purpura Therapeutics Product Introduction, Application and Specification
Table Merck & Co., Inc. Immune Thrombocytopenic Purpura Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Merck & Co., Inc. Immune Thrombocytopenic Purpura Therapeutics Production Growth Rate (2014-2019)
Table Merck & Co., Inc. Immune Thrombocytopenic Purpura Therapeutics Production Market Share (2014-2019)
Figure Merck & Co., Inc. Immune Thrombocytopenic Purpura Therapeutics Revenue Market Share (2014-2019)
Table Merck & Co., Inc. Immune Thrombocytopenic Purpura Therapeutics Main Business and Markets Served
Table Momenta Pharmaceuticals, Inc. Immune Thrombocytopenic Purpura Therapeutics Production Sites and Area Served
Table Novartis AG Immune Thrombocytopenic Purpura Therapeutics Production Sites and Area Served
Table Pfizer Inc. Immune Thrombocytopenic Purpura Therapeutics Production Sites and Area Served
Figure Global Immune Thrombocytopenic Purpura Therapeutics Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Immune Thrombocytopenic Purpura Therapeutics Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Immune Thrombocytopenic Purpura Therapeutics Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Immune Thrombocytopenic Purpura Therapeutics Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Immune Thrombocytopenic Purpura Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Immune Thrombocytopenic Purpura Therapeutics Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Immune Thrombocytopenic Purpura Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Immune Thrombocytopenic Purpura Therapeutics Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Immune Thrombocytopenic Purpura Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Immune Thrombocytopenic Purpura Therapeutics Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Immune Thrombocytopenic Purpura Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Immune Thrombocytopenic Purpura Therapeutics Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Immune Thrombocytopenic Purpura Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Immune Thrombocytopenic Purpura Therapeutics Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Immune Thrombocytopenic Purpura Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Immune Thrombocytopenic Purpura Therapeutics by Type (2019-2025)
Table Global Consumption (K Pcs) of Immune Thrombocytopenic Purpura Therapeutics by Application (2019-2025)
Table Immune Thrombocytopenic Purpura Therapeutics Distributors List
Table Immune Thrombocytopenic Purpura Therapeutics Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Amgen Inc.、Baxalta Incorporated、Boehringer Ingelheim GmbH、Bristol-Myers Squibb Company、Eisai、Hansa Medical AB、Immunomedics, Inc.、Intas Pharmaceuticals Ltd.、Jiangsu Hengrui Medicine Co., Ltd.、Merck & Co., Inc.、Momenta Pharmaceuticals, Inc.、Novartis AG、Pfizer Inc.、

★調査レポート[世界の免疫性血小板減少性紫斑病治療薬市場 2019年] (コード：DATA909X09560)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の免疫性血小板減少性紫斑病治療薬市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 免疫性血小板減少薬の世界市場：規模・現状・予測2019-2025
    DATA909X18558 / QYResearch / 2019年11月25日 / ※当調査レポートでは、免疫性血小板減少薬の世界市場について調査・分析し、免疫性血小板減少薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（トロンボポエチン受容体作動薬（TPO-RA）、コルチコステロイド、静脈内免疫グロブリン（IVIG）、その他薬物）、用途別（バイオテクノロジー及び製薬会社、病院及び診断センター、学術機関及び研究機関）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の免疫性血小板減少薬市場動向 ・主要企業別マーケットシェア ・免疫性血小板減少薬の種類別市場規模2014-2019 （トロンボポエチン受容体作動薬（TPO-RA）、コルチコステロイド、静脈内免疫グロブリン（IVIG）、その他薬物） ・免疫性血小板減少薬の用途別市場規模2014-2019 （バイオテクノロジー及び製薬会社、病院及び診断センター、学術機関及び研究機関） ・免疫性血小板減少薬の北米市場：主要企業・種類別/用途別市場規模 ・免疫性血小板減少薬のヨーロッパ市場：主要企業・種類別/用途別市場規模...Thrombocytopenia is a condition characterized by abnormally low levels of thrombocytes, also known as platelets, in the blood.End-users prefer biosimilars over biologics because of their low cost. The low cost of biosimilars can be attributed to the fewer number of clinical trials required for approval. The upcoming expiration of patents in the immune thrombocytopenia drugs market will fuel the development of biosimilars for those products. For instance, the forthcoming expiration of patents of Nplate (romiplostim) and rituximab has encouraged market vendors to develop their biosimilars. This will also create several opportunities for new vendors to enter the market. Hence, the...
  • 世界の肝不全治療薬市場 2019年
    DATA909X10684 / QYResearch / 2019年11月20日 / ※本調査レポートは、肝不全治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、オルニチンフェニルアセテート、MTL-CEBPA、F-573、BL-1220、PP-100、その他に、用途別には、クリニック、病院、その他にセグメント区分し、肝不全治療薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・肝不全治療薬の世界市場概要 ・肝不全治療薬の製造コスト構成分析 ・肝不全治療薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・肝不全治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・肝不全治療薬のセグメント分析（種類別） （オルニチンフェニルアセテート、MTL-CEBPA、F-573、BL-1220、PP-100、その他）...The global Liver Failure Therapeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Liver Failure Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Liver Failure Therapeutics market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Liver Failure Therapeutics in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の免疫抗阻害剤産業：成長傾向・競合分析2019-2025
    DATA909X01193 / QYResearch / 2019年11月22日 / ※本調査レポートでは、世界の免疫抗阻害剤市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。免疫抗阻害剤の種類別には、組換え免疫抑制剤、血漿由来免疫抑制剤、その他に、用途別には、病院薬局、オンライン薬局、小売薬局に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査レポートの概要 ・グローバル成長傾向・産業動向 ・企業別市場シェア ・免疫抗阻害剤の種類別市場規模：組換え免疫抑制剤、血漿由来免疫抑制剤、その他 ・免疫抗阻害剤の用途別市場規模：病院薬局、オンライン薬局、小売薬局 ・免疫抗阻害剤の地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ ・主要企業のプロフィール：Shire、Baxter、Roche、Novo Nordisk、CSL ・市場規模予測2019-2025：生産量...Immune inhibitors are associated with haemophilia and inhibitors are antibodies developed in haemophilia patients. Haemophilia is a hereditary bleeding disorder, which occurs due to deficiency or absence of clotting factor VIII (haemophilia A) or clotting factor IX (haemophilia B).In 2018, the global Immune Anti-Inhibitor market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Immune Anti-Inhibitor. This study researches the market size...
  • 世界の滑膜肉腫治療市場 2019年
    DATA909X16200 / QYResearch / 2019年11月20日 / ※本調査レポートは、滑膜肉腫治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ACXT-3102、AL-3818、アキシチニブ、CMB-305、CUE-102、その他に、用途別には、病院、診療所、その他にセグメント区分し、滑膜肉腫治療の世界市場を分析しました。 ・エグゼクティブ・サマリー ・滑膜肉腫治療の世界市場概要 ・滑膜肉腫治療の製造コスト構成分析 ・滑膜肉腫治療の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・滑膜肉腫治療の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・滑膜肉腫治療のセグメント分析（種類別） （ACXT-3102、AL-3818、アキシチニブ、CMB-305、CUE-102、その他）...The global Synovial Sarcoma Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Synovial Sarcoma Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Synovial Sarcoma Treatment market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Synovial Sarcoma Treatment in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...

    • ◆H&Iグローバルリサーチのお客様（例）◆